Skip to main content
Aniket Bhatt Articling Student in Toronto

Aniket Bhatt

Associate Fasken
Government decisions can shift market conditions overnight. The right legal guidance can help organizations navigate these shifts.
Jurisdiction Ontario, 2023
Language(s) English
Office(s) Toronto, Ottawa
Contact
Share
  • LinkedIn

Overview

Aniket Bhatt is an associate in Fasken's Political Law practice and is also a member of the firm's Government Relations and Strategy practice. Aniket also maintains a broad corporate/commercial practice and regularly advises public and private clients on a variety of matters. 

As a political law practitioner, Aniket advises on conflict of interest, lobbyist registration, lobbying law-compliance, and election finance, among other political law issues. He also provides support to our resident municipal integrity commissioner on code of conduct and conflict of interest issues.

In addition, Aniket advises businesses, industry associations, and non-profit organizations on a range of matters related to government relations and strategy as well as corporate governance.

Aniket graduated from the University of Ottawa, Faculty of Law, with distinction. Prior to law school, he completed his undergraduate studies at Western University. Aniket also serves as the Director of Research for H2GO Canada, a not-for-profit corporation focused on accelerating the development of a market for hydrogen and remains an active advocate for renewable energy. During his legal studies, Aniket founded a legal innovation start-up that allows organizations to automate environmental, social, and governance (ESG) strategy and disclosure. He also hosts a podcast focused on regulatory developments in ESG and sustainability.

Aniket summered and articled with the firm, during which he was seconded to Noetic Fund, a venture capital firm.

In his spare time, Aniket enjoys reading history, listening to podcasts, drinking espresso, and watching football and Formula 1.

Client Work

  • Edesa Biotech secures up to C$23 million in funding under the Federal Government’s Strategic Innovation Fund for pivotal clinical study, [Deal - Edesa Biotech, Inc.], Clinical-stage biopharmaceutical company secures funding for Phase 3 clinical study of a first-in-class therapeutic candidate.
  • Transdev Canada announces the acquisition of Priority Patient Transfer Service Inc, [Deal - Transdev Canada Inc.], Transdev Canada strengthens its medical transportation activities in Ontario with the acquisition of Priority Patient Transfer Service Inc.

Career & Education

Education

  • JD University of Ottawa
  • BSc University of Western Ontario

Knowledge

News

    Subscribe

    Receive email updates from our team

    Subscribe